![Sanj Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sanj Patel
Oprichter bij
Sarcoma Foundation of America
Vermogen: 85 M $ op 31-05-2026
Profiel
Sanj K.
Patel is the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, serving as Chairman & Chief Executive Officer.
Mr. Patel is the founder of Sarcoma Foundation of America, founded in 2015, serving as Director.
Current jobs include Chairman & Chief Executive Officer at Kiniksa Pharmaceuticals International Plc since 2024 and President at Kiniksa Pharmaceuticals Corp.
Former jobs include President, Chief Executive Officer & Director at Synageva BioPharma Corp.
from 2008 to 2015; Independent Director at BioCryst Pharmaceuticals, Inc. from 2015 to 2018; Independent Director at Intercept Pharmaceuticals, Inc. from 2014 to 2015; Independent Director at Syros Pharmaceuticals, Inc. from 2016 to 2018; and Head-Global Clinical Research Operations Council at Genzyme Corp.
from 1999 to 2008.
Education includes undergraduate studies at London South Bank University and graduate studies at Ealing Hammersmith & West London College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
2,46% | 01-06-2026 | 1.137.763 ( 2,46% ) | 55 M $ | 31-05-2026 |
15,25% | 01-06-2026 | 626.160 ( 15,25% ) | 30 M $ | 31-05-2026 |
Actieve functies van Sanj Patel
| Bedrijven | Functie | Begin |
|---|---|---|
Sarcoma Foundation of America
 Sarcoma Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Oprichter | 01-01-2015 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Algemeen Directeur | 01-01-2015 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | President | - |
Eerdere bekende functies van Sanj Patel
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 20-06-2018 |
| SYROS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 14-06-2018 |
| INTERCEPT PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 24-11-2015 |
| SYNAGEVA BIOPHARMA CORP | Algemeen Directeur | 22-06-2015 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01-01-2008 |
Opleiding van Sanj Patel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
London South Bank University
 London South Bank University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Sarcoma Foundation of America
Sarcoma Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Ealing Hammersmith & West London College
 Ealing Hammersmith & West London College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
